國立虎尾科技大學 |

SARS-CoV-2 Spike Protein Convergent Evolution = Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	SARS-CoV-2 Spike Protein Convergent Evolution/ by Daniele Focosi.
Reminder of title:	Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines /
Author:	Focosi, Daniele.
Description:	XIII, 136 p. 11 illus., 2 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Virology. -
Online resource:	https://doi.org/10.1007/978-3-030-87324-0
ISBN:	9783030873240

SARS-CoV-2 Spike Protein Convergent Evolution = Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines /
Focosi, Daniele.

SARS-CoV-2 Spike Protein Convergent EvolutionImpact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines /[electronic resource] :by Daniele Focosi. - 1st ed. 2021. - XIII, 136 p. 11 illus., 2 illus. in color.online resource. - SpringerBriefs in Microbiology,2191-5393. - SpringerBriefs in Microbiology,.

Chapter 1. Why the Spike protein is relevant for COVID19 therapeutics -- Chapter 2. SARS-CoV-2 variants -- Chapter 3. Conclusion.

This book reviews the current knowledge of the globally circulating SARS-CoV-2 variants, highlights their distinct genetic characteristics and associated conformational changes in the viral spike protein, and profoundly discusses the mechanisms of convergent evolution that led to the rise of these mutated strains at different geographic regions during the Covid-19 pandemic. Furthermore, the book explores how these variants do and may impact the efficacy of established neutralizing antibody-based (nAb) vaccines and therapeutics by analysing latest in vivo and in vitro clinical data. Finally, the author discusses ways on how nAb Covid-19 treatment derived immune escape of SARS-CoV-2 could be minimized in the future.

ISBN: 9783030873240

Standard No.: 10.1007/978-3-030-87324-0doiSubjects--Topical Terms:

644995
Virology.

LC Class. No.: QR355-502

Dewey Class. No.: 616.9101

SARS-CoV-2 Spike Protein Convergent Evolution = Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines /
LDR:02302nam a22003975i 4500 001 1055994
003 DE-He213
005 20211011061046.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030873240 $9 978-3-030-87324-0
024 7 $a 10.1007/978-3-030-87324-0 $2 doi
035 $a 978-3-030-87324-0
050 4 $a QR355-502
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9101 $2 23
100 1 $a Focosi, Daniele. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1115280
245 1 0 $a SARS-CoV-2 Spike Protein Convergent Evolution $h [electronic resource] : $b Impact of Virus Variants on Efficacy of COVID-19 Therapeutics and Vaccines / $c by Daniele Focosi.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIII, 136 p. 11 illus., 2 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Microbiology, $x 2191-5393
505 0 $a Chapter 1. Why the Spike protein is relevant for COVID19 therapeutics -- Chapter 2. SARS-CoV-2 variants -- Chapter 3. Conclusion.
520 $a This book reviews the current knowledge of the globally circulating SARS-CoV-2 variants, highlights their distinct genetic characteristics and associated conformational changes in the viral spike protein, and profoundly discusses the mechanisms of convergent evolution that led to the rise of these mutated strains at different geographic regions during the Covid-19 pandemic. Furthermore, the book explores how these variants do and may impact the efficacy of established neutralizing antibody-based (nAb) vaccines and therapeutics by analysing latest in vivo and in vitro clinical data. Finally, the author discusses ways on how nAb Covid-19 treatment derived immune escape of SARS-CoV-2 could be minimized in the future.
650 0 $a Virology. $3 644995
650 0 $a Immunology. $3 592892
650 0 $a Medical microbiology. $3 583124
650 0 $a Microbial genetics. $3 582864
650 0 $a Microbial genomics. $3 782637
650 2 4 $a Medical Microbiology. $3 668401
650 2 4 $a Microbial Genetics and Genomics. $3 668641
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030873233
776 0 8 $i Printed edition: $z 9783030873257
830 0 $a SpringerBriefs in Microbiology, $x 2191-5385 $3 1255406
856 4 0 $u https://doi.org/10.1007/978-3-030-87324-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)